The global Galectin-3 Inhibitor market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The U.S. market is estimated at $ million in 2024, while China is to reach $ million.
Natural segment will reach $ million by 2032, with a % CAGR in next six years.
The global key players of Galectin-3 Inhibitor include GlycoMimetics (US), Galectin Therapeutics Inc (US), G3 Pharmaceuticals (India), iTeos (US), MandalMed, Inc (US), Angion (US), Novartis AG (Switzerland), Galecto Biotech (Denmark), Pfizer Inc. (US), Lilly (US), etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Galectin-3 Inhibitor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Galectin-3 Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Galectin-3 Inhibitor. This report contains market size and forecasts of Galectin-3 Inhibitor in global, including the following market information:
Global Galectin-3 Inhibitor market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Galectin-3 Inhibitor companies in 2024 (%)
Total Market by Segment:
Global Galectin-3 Inhibitor market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Galectin-3 Inhibitor market segment percentages, by Type, 2024 (%)
Natural
Synthetic
Global Galectin-3 Inhibitor market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Galectin-3 Inhibitor market segment percentages, by Application, 2024 (%)
Diabetes
Heart Failure
Asthma
Rheumatoid Arthritis
Other
Global Galectin-3 Inhibitor market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Galectin-3 Inhibitor market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Galectin-3 Inhibitor revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Galectin-3 Inhibitor revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlycoMimetics (US)
Galectin Therapeutics Inc (US)
G3 Pharmaceuticals (India)
iTeos (US)
MandalMed, Inc (US)
Angion (US)
Novartis AG (Switzerland)
Galecto Biotech (Denmark)
Pfizer Inc. (US)
Lilly (US)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Galectin-3 Inhibitor, market overview.
Chapter 2: Global Galectin-3 Inhibitor market size in revenue.
Chapter 3: Detailed analysis of Galectin-3 Inhibitor company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Galectin-3 Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Galectin-3 Inhibitor Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Galectin-3 Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Galectin-3 Inhibitor Overall Market Size
2.1 Global Galectin-3 Inhibitor Market Size: 2024 VS 2032
2.2 Global Galectin-3 Inhibitor Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Galectin-3 Inhibitor Players in Global Market
3.2 Top Global Galectin-3 Inhibitor Companies Ranked by Revenue
3.3 Global Galectin-3 Inhibitor Revenue by Companies
3.4 Top 3 and Top 5 Galectin-3 Inhibitor Companies in Global Market, by Revenue in 2024
3.5 Global Companies Galectin-3 Inhibitor Product Type
3.6 Tier 1, Tier 2, and Tier 3 Galectin-3 Inhibitor Players in Global Market
3.6.1 List of Global Tier 1 Galectin-3 Inhibitor Companies
3.6.2 List of Global Tier 2 and Tier 3 Galectin-3 Inhibitor Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Galectin-3 Inhibitor Market Size Markets, 2024 & 2032
4.1.2 Natural
4.1.3 Synthetic
4.2 Segmentation by Type - Global Galectin-3 Inhibitor Revenue & Forecasts
4.2.1 Segmentation by Type - Global Galectin-3 Inhibitor Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Galectin-3 Inhibitor Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Galectin-3 Inhibitor Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Galectin-3 Inhibitor Market Size, 2024 & 2032
5.1.2 Diabetes
5.1.3 Heart Failure
5.1.4 Asthma
5.1.5 Rheumatoid Arthritis
5.1.6 Other
5.2 Segmentation by Application - Global Galectin-3 Inhibitor Revenue & Forecasts
5.2.1 Segmentation by Application - Global Galectin-3 Inhibitor Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Galectin-3 Inhibitor Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Galectin-3 Inhibitor Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Galectin-3 Inhibitor Market Size, 2024 & 2032
6.2 By Region - Global Galectin-3 Inhibitor Revenue & Forecasts
6.2.1 By Region - Global Galectin-3 Inhibitor Revenue, 2020-2025
6.2.2 By Region - Global Galectin-3 Inhibitor Revenue, 2026-2032
6.2.3 By Region - Global Galectin-3 Inhibitor Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Galectin-3 Inhibitor Revenue, 2020-2032
6.3.2 United States Galectin-3 Inhibitor Market Size, 2020-2032
6.3.3 Canada Galectin-3 Inhibitor Market Size, 2020-2032
6.3.4 Mexico Galectin-3 Inhibitor Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Galectin-3 Inhibitor Revenue, 2020-2032
6.4.2 Germany Galectin-3 Inhibitor Market Size, 2020-2032
6.4.3 France Galectin-3 Inhibitor Market Size, 2020-2032
6.4.4 U.K. Galectin-3 Inhibitor Market Size, 2020-2032
6.4.5 Italy Galectin-3 Inhibitor Market Size, 2020-2032
6.4.6 Russia Galectin-3 Inhibitor Market Size, 2020-2032
6.4.7 Nordic Countries Galectin-3 Inhibitor Market Size, 2020-2032
6.4.8 Benelux Galectin-3 Inhibitor Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Galectin-3 Inhibitor Revenue, 2020-2032
6.5.2 China Galectin-3 Inhibitor Market Size, 2020-2032
6.5.3 Japan Galectin-3 Inhibitor Market Size, 2020-2032
6.5.4 South Korea Galectin-3 Inhibitor Market Size, 2020-2032
6.5.5 Southeast Asia Galectin-3 Inhibitor Market Size, 2020-2032
6.5.6 India Galectin-3 Inhibitor Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Galectin-3 Inhibitor Revenue, 2020-2032
6.6.2 Brazil Galectin-3 Inhibitor Market Size, 2020-2032
6.6.3 Argentina Galectin-3 Inhibitor Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Galectin-3 Inhibitor Revenue, 2020-2032
6.7.2 Turkey Galectin-3 Inhibitor Market Size, 2020-2032
6.7.3 Israel Galectin-3 Inhibitor Market Size, 2020-2032
6.7.4 Saudi Arabia Galectin-3 Inhibitor Market Size, 2020-2032
6.7.5 UAE Galectin-3 Inhibitor Market Size, 2020-2032
7 Companies Profiles
7.1 GlycoMimetics (US)
7.1.1 GlycoMimetics (US) Corporate Summary
7.1.2 GlycoMimetics (US) Business Overview
7.1.3 GlycoMimetics (US) Galectin-3 Inhibitor Major Product Offerings
7.1.4 GlycoMimetics (US) Galectin-3 Inhibitor Revenue in Global Market (2020-2025)
7.1.5 GlycoMimetics (US) Key News & Latest Developments
7.2 Galectin Therapeutics Inc (US)
7.2.1 Galectin Therapeutics Inc (US) Corporate Summary
7.2.2 Galectin Therapeutics Inc (US) Business Overview
7.2.3 Galectin Therapeutics Inc (US) Galectin-3 Inhibitor Major Product Offerings
7.2.4 Galectin Therapeutics Inc (US) Galectin-3 Inhibitor Revenue in Global Market (2020-2025)
7.2.5 Galectin Therapeutics Inc (US) Key News & Latest Developments
7.3 G3 Pharmaceuticals (India)
7.3.1 G3 Pharmaceuticals (India) Corporate Summary
7.3.2 G3 Pharmaceuticals (India) Business Overview
7.3.3 G3 Pharmaceuticals (India) Galectin-3 Inhibitor Major Product Offerings
7.3.4 G3 Pharmaceuticals (India) Galectin-3 Inhibitor Revenue in Global Market (2020-2025)
7.3.5 G3 Pharmaceuticals (India) Key News & Latest Developments
7.4 iTeos (US)
7.4.1 iTeos (US) Corporate Summary
7.4.2 iTeos (US) Business Overview
7.4.3 iTeos (US) Galectin-3 Inhibitor Major Product Offerings
7.4.4 iTeos (US) Galectin-3 Inhibitor Revenue in Global Market (2020-2025)
7.4.5 iTeos (US) Key News & Latest Developments
7.5 MandalMed, Inc (US)
7.5.1 MandalMed, Inc (US) Corporate Summary
7.5.2 MandalMed, Inc (US) Business Overview
7.5.3 MandalMed, Inc (US) Galectin-3 Inhibitor Major Product Offerings
7.5.4 MandalMed, Inc (US) Galectin-3 Inhibitor Revenue in Global Market (2020-2025)
7.5.5 MandalMed, Inc (US) Key News & Latest Developments
7.6 Angion (US)
7.6.1 Angion (US) Corporate Summary
7.6.2 Angion (US) Business Overview
7.6.3 Angion (US) Galectin-3 Inhibitor Major Product Offerings
7.6.4 Angion (US) Galectin-3 Inhibitor Revenue in Global Market (2020-2025)
7.6.5 Angion (US) Key News & Latest Developments
7.7 Novartis AG (Switzerland)
7.7.1 Novartis AG (Switzerland) Corporate Summary
7.7.2 Novartis AG (Switzerland) Business Overview
7.7.3 Novartis AG (Switzerland) Galectin-3 Inhibitor Major Product Offerings
7.7.4 Novartis AG (Switzerland) Galectin-3 Inhibitor Revenue in Global Market (2020-2025)
7.7.5 Novartis AG (Switzerland) Key News & Latest Developments
7.8 Galecto Biotech (Denmark)
7.8.1 Galecto Biotech (Denmark) Corporate Summary
7.8.2 Galecto Biotech (Denmark) Business Overview
7.8.3 Galecto Biotech (Denmark) Galectin-3 Inhibitor Major Product Offerings
7.8.4 Galecto Biotech (Denmark) Galectin-3 Inhibitor Revenue in Global Market (2020-2025)
7.8.5 Galecto Biotech (Denmark) Key News & Latest Developments
7.9 Pfizer Inc. (US)
7.9.1 Pfizer Inc. (US) Corporate Summary
7.9.2 Pfizer Inc. (US) Business Overview
7.9.3 Pfizer Inc. (US) Galectin-3 Inhibitor Major Product Offerings
7.9.4 Pfizer Inc. (US) Galectin-3 Inhibitor Revenue in Global Market (2020-2025)
7.9.5 Pfizer Inc. (US) Key News & Latest Developments
7.10 Lilly (US)
7.10.1 Lilly (US) Corporate Summary
7.10.2 Lilly (US) Business Overview
7.10.3 Lilly (US) Galectin-3 Inhibitor Major Product Offerings
7.10.4 Lilly (US) Galectin-3 Inhibitor Revenue in Global Market (2020-2025)
7.10.5 Lilly (US) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Galectin-3 Inhibitor Market Opportunities & Trends in Global Market
Table 2. Galectin-3 Inhibitor Market Drivers in Global Market
Table 3. Galectin-3 Inhibitor Market Restraints in Global Market
Table 4. Key Players of Galectin-3 Inhibitor in Global Market
Table 5. Top Galectin-3 Inhibitor Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Galectin-3 Inhibitor Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Galectin-3 Inhibitor Revenue Share by Companies, 2020-2025
Table 8. Global Companies Galectin-3 Inhibitor Product Type
Table 9. List of Global Tier 1 Galectin-3 Inhibitor Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Galectin-3 Inhibitor Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Galectin-3 Inhibitor Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Galectin-3 Inhibitor Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Galectin-3 Inhibitor Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Galectin-3 Inhibitor Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Galectin-3 Inhibitor Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Galectin-3 Inhibitor Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Galectin-3 Inhibitor Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Galectin-3 Inhibitor Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Galectin-3 Inhibitor Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Galectin-3 Inhibitor Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Galectin-3 Inhibitor Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Galectin-3 Inhibitor Revenue, (US$, Mn), 2026-2032
Table 30. GlycoMimetics (US) Corporate Summary
Table 31. GlycoMimetics (US) Galectin-3 Inhibitor Product Offerings
Table 32. GlycoMimetics (US) Galectin-3 Inhibitor Revenue (US$, Mn) & (2020-2025)
Table 33. GlycoMimetics (US) Key News & Latest Developments
Table 34. Galectin Therapeutics Inc (US) Corporate Summary
Table 35. Galectin Therapeutics Inc (US) Galectin-3 Inhibitor Product Offerings
Table 36. Galectin Therapeutics Inc (US) Galectin-3 Inhibitor Revenue (US$, Mn) & (2020-2025)
Table 37. Galectin Therapeutics Inc (US) Key News & Latest Developments
Table 38. G3 Pharmaceuticals (India) Corporate Summary
Table 39. G3 Pharmaceuticals (India) Galectin-3 Inhibitor Product Offerings
Table 40. G3 Pharmaceuticals (India) Galectin-3 Inhibitor Revenue (US$, Mn) & (2020-2025)
Table 41. G3 Pharmaceuticals (India) Key News & Latest Developments
Table 42. iTeos (US) Corporate Summary
Table 43. iTeos (US) Galectin-3 Inhibitor Product Offerings
Table 44. iTeos (US) Galectin-3 Inhibitor Revenue (US$, Mn) & (2020-2025)
Table 45. iTeos (US) Key News & Latest Developments
Table 46. MandalMed, Inc (US) Corporate Summary
Table 47. MandalMed, Inc (US) Galectin-3 Inhibitor Product Offerings
Table 48. MandalMed, Inc (US) Galectin-3 Inhibitor Revenue (US$, Mn) & (2020-2025)
Table 49. MandalMed, Inc (US) Key News & Latest Developments
Table 50. Angion (US) Corporate Summary
Table 51. Angion (US) Galectin-3 Inhibitor Product Offerings
Table 52. Angion (US) Galectin-3 Inhibitor Revenue (US$, Mn) & (2020-2025)
Table 53. Angion (US) Key News & Latest Developments
Table 54. Novartis AG (Switzerland) Corporate Summary
Table 55. Novartis AG (Switzerland) Galectin-3 Inhibitor Product Offerings
Table 56. Novartis AG (Switzerland) Galectin-3 Inhibitor Revenue (US$, Mn) & (2020-2025)
Table 57. Novartis AG (Switzerland) Key News & Latest Developments
Table 58. Galecto Biotech (Denmark) Corporate Summary
Table 59. Galecto Biotech (Denmark) Galectin-3 Inhibitor Product Offerings
Table 60. Galecto Biotech (Denmark) Galectin-3 Inhibitor Revenue (US$, Mn) & (2020-2025)
Table 61. Galecto Biotech (Denmark) Key News & Latest Developments
Table 62. Pfizer Inc. (US) Corporate Summary
Table 63. Pfizer Inc. (US) Galectin-3 Inhibitor Product Offerings
Table 64. Pfizer Inc. (US) Galectin-3 Inhibitor Revenue (US$, Mn) & (2020-2025)
Table 65. Pfizer Inc. (US) Key News & Latest Developments
Table 66. Lilly (US) Corporate Summary
Table 67. Lilly (US) Galectin-3 Inhibitor Product Offerings
Table 68. Lilly (US) Galectin-3 Inhibitor Revenue (US$, Mn) & (2020-2025)
Table 69. Lilly (US) Key News & Latest Developments
List of Figures
Figure 1. Galectin-3 Inhibitor Product Picture
Figure 2. Galectin-3 Inhibitor Segment by Type in 2024
Figure 3. Galectin-3 Inhibitor Segment by Application in 2024
Figure 4. Global Galectin-3 Inhibitor Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Galectin-3 Inhibitor Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Galectin-3 Inhibitor Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Galectin-3 Inhibitor Revenue in 2024
Figure 9. Segmentation by Type � Global Galectin-3 Inhibitor Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Galectin-3 Inhibitor Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Galectin-3 Inhibitor Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Galectin-3 Inhibitor Revenue Market Share, 2020-2032
Figure 13. By Region - Global Galectin-3 Inhibitor Revenue Market Share, 2020-2032
Figure 14. By Country - North America Galectin-3 Inhibitor Revenue Market Share, 2020-2032
Figure 15. United States Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Galectin-3 Inhibitor Revenue Market Share, 2020-2032
Figure 19. Germany Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 20. France Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Galectin-3 Inhibitor Revenue Market Share, 2020-2032
Figure 27. China Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 31. India Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Galectin-3 Inhibitor Revenue Market Share, 2020-2032
Figure 33. Brazil Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Galectin-3 Inhibitor Revenue Market Share, 2020-2032
Figure 36. Turkey Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Galectin-3 Inhibitor Revenue, (US$, Mn), 2020-2032
Figure 40. GlycoMimetics (US) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Galectin Therapeutics Inc (US) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. G3 Pharmaceuticals (India) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. iTeos (US) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. MandalMed, Inc (US) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Angion (US) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Novartis AG (Switzerland) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Galecto Biotech (Denmark) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Pfizer Inc. (US) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Lilly (US) Galectin-3 Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
